Jaguar Health stock is down on Tuesday as JAGX investors react to failed results from a Phase 3 clinical trial of crofelemer. More
Articles
Wedbush Just Raised Its Price Target on AMC Entertainment (AMC) Stock
AMC is sinking lower after Wedbush raised its price target to $4 from $3.50, calling for share issuances in the coming months. More
Why Is Adial Pharmaceuticals (ADIL) Up 61% Today?
Adial Pharmaceuticals stock is up with heavy trading of ADIL after providing investors with an update on its AD04 clinical trial. More
3 Retail Stocks to Buy Before the Big Back-to-School Boom
You may not be on the hunt for sales on backpacks and notebooks, but this may be a good time to look for retail stocks to buy. More
PNR Stock Earnings: Pentair Beats EPS, Beats Revenue for Q2 2024
PNR stock results show that Pentair beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
AOS Stock Earnings: A.O. Smith Meets EPS, Beats Revenue for Q2 2024
AOS stock results show that A.O. Smith met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
PM Stock Earnings: Philip Morris Intl Beats EPS, Beats Revenue for Q2 2024
PM stock results show that Philip Morris Intl beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
